Northway Biotech
Masazumi Nagai's work experience includes:
- Principal Lead Scientist at Northway Biotech since October 2022 (current position)
- Senior Investigator at AB Biosciences since April 2022 (current position)
- Visiting Professor at Iwate Medical University since March 2017 (current position)
- Lecturer, Oral Medicine Infection and Immunity at Harvard School of Dental Medicine since September 2019 (current position)
- Principal Scientist at Northway Biotech from July 2020 to March 2022
- Sr Scientist at QLB Biotherapeutics from September 2018 to January 2020
- Scientist at Abpro Therapeutics from October 2016 to September 2018
- Principal Scientist at Synta Pharmaceuticals from October 2003 to June 2015
Masazumi Nagai's education history includes attending Harvard School of Dental Medicine, but no specific degree or field of study is provided. In 1975, Nagai attended Iwate Medical University, where they obtained a Doctor of Philosophy (Ph.D.) with a focus on Dentistry/Biochemistry. In 1981, Nagai obtained a certification as a Dentist/Orthodontist.
This person is not in any offices
Northway Biotech
Northway Biotech is a Contract Development and Manufacturing Organization (CDMO) located in Waltham, MA, USA, and Vilnius, Lithuania, EU. Extensive expertise in drug substance and drug product development, as well as GMP compliant manufacturing, makes us exceptionally well-versed in all aspects of the biopharmaceutical value chain – from gene to drug manufacturing in microbial and mammalian expressions systems. Our customers appreciate our ability to react rapidly to unexpected project changes, adjusting timelines, and availability of additional capabilities to meet our customers' evolving needs. We are deeply invested in providing high-quality, world-class contract development and manufacturing services with vast flexibility and responsiveness backed by a strong foundation in science and technology innovation. Northway Biotech end-to-end services include: Cell Line (Mammalian & Microbial) Development Analytical Methods Development Formulation Development Upstream & Downstream Process Development (USP & DSP) cGMP Manufacturing of Biologics & Biosimilars (Drug Substance, Drug Product) cGMP Master and Working Cell Bank Manufacturing cGMP pDNA Manufacturing Fill & Finish (F&F) Quality Assurance, Quality Control, and Regulatory CMC Support